N-[[4-[5-(3H-benzimidazol-5-yl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-(5-benzyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-N-[[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-4-pentylbenzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-pentyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-[5-(3,3,3-trifluoropropyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]benzamide
C251H326F3N31O14 — CID 159813237
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[4-[5-(3H-benzimidazol-5-yl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-(5-benzyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-N-[[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-4-pentylbenzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-pentyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-[5-(3,3,3-trifluoropropyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]benzamide
N-[[4-[5-(3H-benzimidazol-5-yl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-(5-benzyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-N-[[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-4-pentylbenzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-pentyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-[5-(3,3,3-trifluoropropyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]benzamide (PubChem CID 159813237) has the molecular formula C251H326F3N31O14 and a molecular weight of 4058.57 g/mol. Its IUPAC name is N-[[4-[5-(3H-benzimidazol-5-yl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-(5-benzyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-N-[[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-4-pentylbenzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-pentyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-[5-(3,3,3-trifluoropropyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]benzamide.
Molecular Properties
| Compound Name | N-[[4-[5-(3H-benzimidazol-5-yl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-(5-benzyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-N-[[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-4-pentylbenzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-pentyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-[5-(3,3,3-trifluoropropyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]benzamide |
|---|---|
| PubChem CID | 159813237 |
| Molecular Formula | C251H326F3N31O14 |
| Molecular Weight | 4058.57 g/mol |
| Exact Mass | 4055.57 |
| IUPAC Name | N-[[4-[5-(3H-benzimidazol-5-yl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-(5-benzyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-N-[[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-4-pentylbenzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-pentyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-pyridin-3-yl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-[5-(3,3,3-trifluoropropyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]benzamide |
| SMILES | CCCCCc1ccc(C(=O)N(Cc2ccc(-c3noc(-c4ccc5nc[nH]c5c4)n3)cc2)C2CCN(CCC(C)C)CC2)cc1.CCCCCc1ccc(C(=O)N(Cc2ccc(-c3noc(-c4ccccc4)n3)cc2)C2CCN(CCC(C)C)CC2)cc1.CCCCCc1ccc(C(=O)N(Cc2ccc(-c3noc(-c4cccnc4)n3)cc2)C2CCN(CCC(C)C)CC2)cc1.CCCCCc1ccc(C(=O)N(Cc2ccc(-c3noc(C)n3)cc2)C2CCN(CCC(C)C)CC2)cc1.CCCCCc1ccc(C(=O)N(Cc2ccc(-c3noc(CCC(F)(F)F)n3)cc2)C2CCN(CCC(C)C)CC2)cc1.CCCCCc1ccc(C(=O)N(Cc2ccc(-c3noc(CCCCC)n3)cc2)C2CCN(CCC(C)C)CC2)cc1.CCCCCc1ccc(C(=O)N(Cc2ccc(-c3noc(Cc4ccccc4)n3)cc2)C2CCN(CCC(C)C)CC2)cc1 |
| InChI | InChI=1S/C38H46N6O2.C38H48N4O2.C37H46N4O2.C36H45N5O2.C36H52N4O2.C34H45F3N4O2.C32H44N4O2/c1-4-5-6-7-28-8-14-31(15-9-28)38(45)44(33-19-22-43(23-20-33)21-18-27(2)3)25-29-10-12-30(13-11-29)36-41-37(46-42-36)32-16-17-34-35(24-32)40-26-39-34;1-4-5-7-10-30-13-19-34(20-14-30)38(43)42(35-22-25-41(26-23-35)24-21-29(2)3)28-32-15-17-33(18-16-32)37-39-36(44-40-37)27-31-11-8-6-9-12-31;1-4-5-7-10-29-13-19-33(20-14-29)37(42)41(34-22-25-40(26-23-34)24-21-28(2)3)27-30-15-17-31(18-16-30)35-38-36(43-39-35)32-11-8-6-9-12-32;1-4-5-6-8-28-10-16-31(17-11-28)36(42)41(33-19-23-40(24-20-33)22-18-27(2)3)26-29-12-14-30(15-13-29)34-38-35(43-39-34)32-9-7-21-37-25-32;1-5-7-9-11-29-13-19-32(20-14-29)36(41)40(33-22-25-39(26-23-33)24-21-28(3)4)27-30-15-17-31(18-16-30)35-37-34(42-38-35)12-10-8-6-2;1-4-5-6-7-26-8-14-29(15-9-26)33(42)41(30-18-22-40(23-19-30)21-17-25(2)3)24-27-10-12-28(13-11-27)32-38-31(43-39-32)16-20-34(35,36)37;1-5-6-7-8-26-9-15-29(16-10-26)32(37)36(30-18-21-35(22-19-30)20-17-24(2)3)23-27-11-13-28(14-12-27)31-33-25(4)38-34-31/h8-17,24,26-27,33H,4-7,18-23,25H2,1-3H3,(H,39,40);6,8-9,11-20,29,35H,4-5,7,10,21-28H2,1-3H3;6,8-9,11-20,28,34H,4-5,7,10,21-27H2,1-3H3;7,9-17,21,25,27,33H,4-6,8,18-20,22-24,26H2,1-3H3;13-20,28,33H,5-12,21-27H2,1-4H3;8-15,25,30H,4-7,16-24H2,1-3H3;9-16,24,30H,5-8,17-23H2,1-4H3 |
| InChIKey | NLHJIJCKAXKQJG-UHFFFAOYSA-N |
| XLogP | 55.75 |
| TPSA | 478.86 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 37 |
| Rotatable Bonds | 95 |
| Heavy Atoms | 299 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4058.57 |
| LogP ≤ 5 | 55.75 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 37 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159813237 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.